Suzhou Announces List of Municipal Enterprise Technology Centers; Singleron Biotechnologies and Abogen Biosciences Included

Singleron BioMoved into BioTop Innovation Space in June 2018., and graduated in February 2019 to continue development at BioBAY, is aA company dedicated to the independent development and clinical transformation of high-throughput single-cell multi-omics platform products. Since its establishment, the company has grown rapidly and now owns a one-stop high-throughput single-cell sequencing platform, providing comprehensive solutions from tissue sample processing, high-throughput single-cell isolation and sequencing library construction, to data analysis and biological significance mining.

Abogen, which was established in March 2019 and located in BioTOP Innovation Space, graduated to BioBAY in June 2020 for further development. It is an innovative biopharmaceutical company focusing on the research and development of messenger ribonucleic acid (mRNA) drugs. The company owns industry-leading, proprietary intellectual property rights over its mRNA and nanodelivery technology platforms. As one of the few mRNA drug R&D enterprises in China with complete value chain capabilities, it covers all aspects from mRNA design, formulation development to large-scale production. Abogen has built a rich product pipeline, spanning multiple fields including infectious disease prevention and control (such as mRNA COVID-19 vaccines), tumor immunotherapy, and protein replacement therapy.